People

Search Language

中文(台灣) / Traditional Chinese | Use language selector above (below, on mobile) to search additional languages
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  • Search
  • Selected filters
  • x(sec enforcement)

1846 items matching filters

Search Results

740

Practice:

  • Complex Litigation & Dispute Resolution
  • Mass Torts & Product Liability
  • Insurance Recovery
  • Class Action Defense
  • Trials

Khai LeQuang Partner

Orange County

Most recently, Khai was lead trial counsel for EFG Bank and Erste Abwicklungsanstalt (which acquired the assets of former WestLB) in their lawsuit against AXA Equitable Life Insurance Company in the Southern District of New York, arising out of Equitable’s cost of insurance rate increase in 2016. EFG and EAA sought close to $100 million in damages. After several years of litigation, the case settled over the weekend before jury selection on very favorable terms. The settlement continued a string of recoveries Khai has achieved for clients pursuing claims against carriers that raised their cost of insurance rates.

Khai was lead trial counsel for EFG, EAA, and Obra Capital in their lawsuit against John Hancock Life Insurance Company in the Southern District of New York, arising out of John Hancock’s cost of insurance rate increase in 2018. EFG, EAA, and Obra sought over $100 million in damages. The case settled the evening before jury selection on very favorable terms.

Last year, Khai was lead trial counsel for a life insurance agent sued for fraud in connection with a life settlement transaction. The plaintiff sought over $10 million in damages. Following a one-week trial, the jury returned a complete defense verdict, and the case settled before judgment was entered.

Khai was lead trial counsel in a two-week bench trial in an action against a school district arising out of its allocation of $417 million in bond funds. The plaintiffs, led by a taxpayer association, sought $90 million for construction of a new school. After navigating a year-long political imbroglio and defeating plaintiffs’ summary judgment motions following a defense that Judge Pressman described as “brilliantly argued,” the case proceeded to a trial that resulted in a decision in favor of the district on all claims. Khai also defended and argued the appeal, in which the trial court’s judgment was affirmed.

740

Practice:

  • Complex Litigation & Dispute Resolution
  • Mass Torts & Product Liability
  • Insurance Recovery
  • Class Action Defense
  • Trials

Khai LeQuang Partner

Orange County

Most recently, Khai was lead trial counsel for EFG Bank and Erste Abwicklungsanstalt (which acquired the assets of former WestLB) in their lawsuit against AXA Equitable Life Insurance Company in the Southern District of New York, arising out of Equitable’s cost of insurance rate increase in 2016. EFG and EAA sought close to $100 million in damages. After several years of litigation, the case settled over the weekend before jury selection on very favorable terms. The settlement continued a string of recoveries Khai has achieved for clients pursuing claims against carriers that raised their cost of insurance rates.

Khai was lead trial counsel for EFG, EAA, and Obra Capital in their lawsuit against John Hancock Life Insurance Company in the Southern District of New York, arising out of John Hancock’s cost of insurance rate increase in 2018. EFG, EAA, and Obra sought over $100 million in damages. The case settled the evening before jury selection on very favorable terms.

Last year, Khai was lead trial counsel for a life insurance agent sued for fraud in connection with a life settlement transaction. The plaintiff sought over $10 million in damages. Following a one-week trial, the jury returned a complete defense verdict, and the case settled before judgment was entered.

Khai was lead trial counsel in a two-week bench trial in an action against a school district arising out of its allocation of $417 million in bond funds. The plaintiffs, led by a taxpayer association, sought $90 million for construction of a new school. After navigating a year-long political imbroglio and defeating plaintiffs’ summary judgment motions following a defense that Judge Pressman described as “brilliantly argued,” the case proceeded to a trial that resulted in a decision in favor of the district on all claims. Khai also defended and argued the appeal, in which the trial court’s judgment was affirmed.

432501

Practice:

  • Financial & Fintech Advisory
  • Strategic Advisory & Government Enforcement (SAGE)
  • Fintech
  • Class Action Defense
  • Complex Litigation & Dispute Resolution
  • Government Investigations and Enforcement Actions

Sarah Davis Counsel

San Francisco

Sarah has particular expertise defending challenges to overdraft fees, including challenges to authorize positive, settle negative (“APSN”) transactions, and has represented Capital One, U.S. Bank, First Hawaiian Bank, and Union Bank in putative class actions challenging APSN fees. Separately, Sarah has defended two large national banks in enforcement actions related to overdraft fees and obtained a non-public resolution of voluntary remediation.

Sarah also has a robust practice defending both small and large companies against allegations of food mislabeling. She has successfully defended or reached favorable settlement terms regarding challenges to “all natural,” “no sugar added,” and “non-GMO” claims.

432501

Practice:

  • Financial & Fintech Advisory
  • Strategic Advisory & Government Enforcement (SAGE)
  • Fintech
  • Class Action Defense
  • Complex Litigation & Dispute Resolution
  • Government Investigations and Enforcement Actions

Sarah Davis Counsel

San Francisco

Sarah has particular expertise defending challenges to overdraft fees, including challenges to authorize positive, settle negative (“APSN”) transactions, and has represented Capital One, U.S. Bank, First Hawaiian Bank, and Union Bank in putative class actions challenging APSN fees. Separately, Sarah has defended two large national banks in enforcement actions related to overdraft fees and obtained a non-public resolution of voluntary remediation.

Sarah also has a robust practice defending both small and large companies against allegations of food mislabeling. She has successfully defended or reached favorable settlement terms regarding challenges to “all natural,” “no sugar added,” and “non-GMO” claims.

287778

Practice:

  • Finance Sector
  • Banking & Finance
  • Private Credit
  • Fintech

B. J. Rosen Partner

New York

B. J. is also the Senior Outside Legal Advisor to The Innocence Project, an organization dedicated to exonerating wrongly-convicted prisoners through DNA testing and reforming the criminal justice system to prevent future injustice.

287778

Practice:

  • Finance Sector
  • Banking & Finance
  • Private Credit
  • Fintech

B. J. Rosen Partner

New York

B. J. is also the Senior Outside Legal Advisor to The Innocence Project, an organization dedicated to exonerating wrongly-convicted prisoners through DNA testing and reforming the criminal justice system to prevent future injustice.

740

Practice:

  • Employment Law & Litigation

Allison Riechert Giese Talent Counsel

Silicon Valley

Orrick’s Employment Law and Litigation group was recently named Labor & Employment Department of the Year in California by The Recorder, the premier source for legal news, in recognition of their significant wins on behalf of leading multinational companies on today’s most complex and challenging employment law matters.

Allison was a summer associate in Orrick's Silicon Valley office in 2008. Prior to joining Orrick, she interned in the San Mateo County Superior Court's legal research department.

740

Practice:

  • Employment Law & Litigation

Allison Riechert Giese Talent Counsel

Silicon Valley

Orrick’s Employment Law and Litigation group was recently named Labor & Employment Department of the Year in California by The Recorder, the premier source for legal news, in recognition of their significant wins on behalf of leading multinational companies on today’s most complex and challenging employment law matters.

Allison was a summer associate in Orrick's Silicon Valley office in 2008. Prior to joining Orrick, she interned in the San Mateo County Superior Court's legal research department.

Guido Testa Partner

Milan

As a partner resident in Orrick’s Milan office and a senior member of the M&A and Private Equity Group, Guido is acclaimed for his broad expertise and comprehensive knowledge in the field.

In the area of M&A, he regularly assists leading corporations, investment holding companies, and family offices in structuring and negotiating domestic and cross-border mergers, acquisitions, and strategic alliances. His experience extends across a range of industries, with a particular focus on the industrial and healthcare sectors, where he is known for his ability to manage sophisticated transactions and deliver practical solutions.

Guido’s private equity practice is distinguished by his work with both investment funds and, above all, entrepreneurs. Guido is a key legal partner to Italian entrepreneurs, advising on all aspects of corporate law and governance. He is valued for his ability to act as a business partner, providing ongoing counsel on day-to-day operations as well as long-term planning and extraordinary transactions. Clients rely on his deep sector knowledge, commercial acumen, and pragmatic approach to navigate complex legal and business challenges. Moreover, he advises investment funds on the structuring and execution of acquisitions and disposals, helping them identify opportunities, manage legal risks, and achieve their strategic objectives in the Italian market.

In the area of joint ventures, Guido has significant experience advising on the formation and management of strategic partnerships and alliances, enabling clients to pursue growth opportunities and innovation in highly competitive markets.

Guido also has extensive cross-border experience, regularly assisting international corporate and funds investing in Italy as well as Italian corporate and funds pursuing opportunities abroad, ensuring seamless execution and effective cross-border coordination.

Guido is recognized as a Leading Partner in Private Equity by Legal 500. He is ranked in Chambers Europe for Private Equity and for Corporate/M&A: Mid-Market, reflecting his strong reputation and expertise in the Italian legal market.

Guido Testa Partner

Milan

As a partner resident in Orrick’s Milan office and a senior member of the M&A and Private Equity Group, Guido is acclaimed for his broad expertise and comprehensive knowledge in the field.

In the area of M&A, he regularly assists leading corporations, investment holding companies, and family offices in structuring and negotiating domestic and cross-border mergers, acquisitions, and strategic alliances. His experience extends across a range of industries, with a particular focus on the industrial and healthcare sectors, where he is known for his ability to manage sophisticated transactions and deliver practical solutions.

Guido’s private equity practice is distinguished by his work with both investment funds and, above all, entrepreneurs. Guido is a key legal partner to Italian entrepreneurs, advising on all aspects of corporate law and governance. He is valued for his ability to act as a business partner, providing ongoing counsel on day-to-day operations as well as long-term planning and extraordinary transactions. Clients rely on his deep sector knowledge, commercial acumen, and pragmatic approach to navigate complex legal and business challenges. Moreover, he advises investment funds on the structuring and execution of acquisitions and disposals, helping them identify opportunities, manage legal risks, and achieve their strategic objectives in the Italian market.

In the area of joint ventures, Guido has significant experience advising on the formation and management of strategic partnerships and alliances, enabling clients to pursue growth opportunities and innovation in highly competitive markets.

Guido also has extensive cross-border experience, regularly assisting international corporate and funds investing in Italy as well as Italian corporate and funds pursuing opportunities abroad, ensuring seamless execution and effective cross-border coordination.

Guido is recognized as a Leading Partner in Private Equity by Legal 500. He is ranked in Chambers Europe for Private Equity and for Corporate/M&A: Mid-Market, reflecting his strong reputation and expertise in the Italian legal market.

Dan Williams Senior Associate

San Francisco

Dan is experienced in Hatch-Waxman litigation, including disputes involving drug treatments for cancer and HIV. Dan is also experienced in biologics litigation and counseling, representing clients on matters involving expression vectors, antibodies, gene therapies, and CAR T-cell therapies. Dan’s experience includes litigating patents directed to recombinant DNA technology, complex manufacturing processes, small molecule compounds, crystalline forms, methods of treatment, oral dosage formulations, injectable formulations, and fixed dose combination products.

Dan has contributed to numerous victories on behalf of our life science clients, including a complete win in a multi-patent Hatch-Waxman trial for a client’s blockbuster cancer therapy, favorable claim constructions in numerous cases, and obtaining a special master’s report and recommendation for attorneys’ fees for the opposing parties’ exceptional discovery misconduct. Dan has courtroom advocacy experience, including presenting to the district court for Markman proceedings.

Dan Williams Senior Associate

San Francisco

Dan is experienced in Hatch-Waxman litigation, including disputes involving drug treatments for cancer and HIV. Dan is also experienced in biologics litigation and counseling, representing clients on matters involving expression vectors, antibodies, gene therapies, and CAR T-cell therapies. Dan’s experience includes litigating patents directed to recombinant DNA technology, complex manufacturing processes, small molecule compounds, crystalline forms, methods of treatment, oral dosage formulations, injectable formulations, and fixed dose combination products.

Dan has contributed to numerous victories on behalf of our life science clients, including a complete win in a multi-patent Hatch-Waxman trial for a client’s blockbuster cancer therapy, favorable claim constructions in numerous cases, and obtaining a special master’s report and recommendation for attorneys’ fees for the opposing parties’ exceptional discovery misconduct. Dan has courtroom advocacy experience, including presenting to the district court for Markman proceedings.